Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly.

2.50
Hdl Handle:
http://hdl.handle.net/10541/84101
Title:
Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly.
Authors:
Peacey, Steven R; Shalet, Stephen M
Abstract:
This article discusses the characteristic features of growth hormone secretion and insulin-like growth factor I (IGF-1) concentrations both in patients with acromegaly and in normal subjects. The therapeutic options for the treatment of acromegaly are briefly discussed, as are the current definitions of successful therapy. The article focuses on the use of serum and urinary growth hormone measurements along with the current and potential use of serum IGF-1, both at diagnosis and during long-term follow-up.
Affiliation:
Department of Diabetes and Endocrinology, Bradford Hospitals NHS Trust, UK.
Citation:
Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly. 2001, 38 (Pt 4):297-303 Ann. Clin. Biochem.
Journal:
Annals of Clinical Biochemistry
Issue Date:
Jul-2001
URI:
http://hdl.handle.net/10541/84101
PubMed ID:
11471869
Type:
Article
Language:
en
ISSN:
0004-5632
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorPeacey, Steven Ren
dc.contributor.authorShalet, Stephen Men
dc.date.accessioned2009-10-12T16:59:16Z-
dc.date.available2009-10-12T16:59:16Z-
dc.date.issued2001-07-
dc.identifier.citationInsulin-like growth factor 1 measurement in diagnosis and management of acromegaly. 2001, 38 (Pt 4):297-303 Ann. Clin. Biochem.en
dc.identifier.issn0004-5632-
dc.identifier.pmid11471869-
dc.identifier.urihttp://hdl.handle.net/10541/84101-
dc.description.abstractThis article discusses the characteristic features of growth hormone secretion and insulin-like growth factor I (IGF-1) concentrations both in patients with acromegaly and in normal subjects. The therapeutic options for the treatment of acromegaly are briefly discussed, as are the current definitions of successful therapy. The article focuses on the use of serum and urinary growth hormone measurements along with the current and potential use of serum IGF-1, both at diagnosis and during long-term follow-up.en
dc.language.isoenen
dc.subject.meshAcromegaly-
dc.subject.meshBiological Markers-
dc.subject.meshHumans-
dc.subject.meshInsulin-Like Growth Factor I-
dc.titleInsulin-like growth factor 1 measurement in diagnosis and management of acromegaly.en
dc.typeArticleen
dc.contributor.departmentDepartment of Diabetes and Endocrinology, Bradford Hospitals NHS Trust, UK.en
dc.identifier.journalAnnals of Clinical Biochemistryen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.